Diagnosis requires one of two key symptoms:
Sad, depressed mood
Loss of pleasure or interest in previously enjoyed activities
Sleep disturbances
Decreased interest
Guilt
Decreased energy
Decreased concentration
Appetite changes
Psychomotor symptoms
Suicidal ideation
Two questions focusing on the main symptoms of depression.
Positive result leads to the full PHQ-9 assessment.
Directly ask patients about thoughts of self-harm.
Inquire about a specific plan.
If a detailed plan exists, refer to the emergency department.
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Safe for older adults (low side effect profile):
Zoloft (sertraline)
Lexapro (escitalopram)
Avoid in older adults (long half-life):
Fluoxetine (Prozac)
Most sedating SSRI:
Paroxetine (Paxil)
Avoid in patients with anxiety:
Fluoxetine (Prozac) - may cause nervousness.
First-line for pediatric depression (when therapy fails):
Fluoxetine (Prozac)
Commonly used options:
Cymbalta (duloxetine)
Effexor (venlafaxine)
Side effects comparable to SSRIs, but SNRIs can increase blood pressure due to norepinephrine effects.
Not ideal for patients with uncontrolled hypertension.
Onset of noticeable effects: 4-6 weeks.
If no relief after 4-6 weeks: Increase dose or investigate other conditions.
Common side effects: GI issues, sexual dysfunction, potential weight gain.
GI effects usually subside after a few weeks.
Treatment duration: Typically 6-12 months after symptoms are under control.
Tricyclic Antidepressants (TCAs) (e.g., nortriptyline):
Not first-line agents due to notable side effects.
Side effects: Weight gain, ECG changes.
Avoid in older adults due to anticholinergic side effects.
Norepinephrine-Dopamine Reuptake Inhibitor (NDRI) - Wellbutrin (bupropion):
Uses: MDD, smoking cessation, seasonal affective disorder, and off-label for ADHD.
Avoid in patients with anxiety and insomnia (may worsen symptoms).
Can reduce sexual dysfunction when added to SSRI therapy.
Avoid with serotonin medications (SSRIs/SNRIs) due to increased risk of serotonin syndrome.
Serotonin syndrome signs/symptoms: Shivering, seizures, tremors, tachycardia, agitation.
Emergency requiring immediate referral.
Worry
Anxiety
Tension
Concentration difficulty
Hyperarousal
Energy loss
Restlessness
Sleep disturbance
Symptoms must be:
Excessive
Difficult to control
Cause functional impairment
Last at least six months
A score of 3 or greater warrants follow-up with the GAD-7.
SSRIs and SNRIs.
Buspirone (Buspar): Not a controlled substance. Can be dosed as needed or consistently
For situational anxiety (e.g., fear of flying) or short-term bridge therapy.
Caution advised due to serious side effects (CNS depression) and risk of dependence.
Develops in response to a traumatic event or experience.
Key symptoms: Nightmares, flashbacks, hypervigilance.
Management: Medication and cognitive behavioral therapy (both first-line).
Preferred Medication Class: SSRIs.
Characterized by difficulty falling asleep, staying asleep, or both.
Leads to daytime sleepiness and impairment.
Initial Treatment: Patient education about sleep hygiene, followed by cognitive behavioral therapy.
Medications:
Over-the-counter (OTC): Benadryl, melatonin.
FDA-approved medications (use cautiously due to side effects).
Non-benzodiazepine receptor agonists (e.g., Ambien): Can cause CNS depression and complex sleep behaviors (sleep driving).
Characterized by extreme mood episodes.
Mania (Bipolar I):
Reduced sleep, impulsive purchases, racing thoughts, extreme excitement.
Followed by low mood symptoms.
First-Line Medication: Lithium (mood stabilizer).
Prescribed by mental health clinicians.
Narrow therapeutic range: 0.6 - 1.2
Levels
less 1.5 indicate risk of toxicity.
Lithium Toxicity Symptoms: Nausea, vomiting, tremors, hyperactive reflexes, confusion, vision changes.
Monitor thyroid gland (long-term use can lead to hypothyroidism).
Used for schizophrenia, mood disorders, treatment-resistant depression.
Not prescribed by primary care clinicians.
Typical (First Generation): Haldol (haloperidol).
Atypical (Second Generation): Zyprexa (olanzapine), Seroquel (quetiapine).
Metabolic Side Effects: Weight gain, hyperglycemia, hyperlipidemia (monitor regularly).
Majority of medications metabolized in the liver via cytochrome P450 (CYP450) enzymes.
Many psych medications are metabolized by CYP3A4, leading to potential drug interactions.
St. John's Wort: CYP3A4 inducer (decreases efficacy of drugs like warfarin, digoxin).
CYP2C19 enzyme activity varies across populations, affecting metabolism of SSRIs.
Genetic variants in some Asian populations may cause different metabolism, effectiveness, or side effects.
Asian patients may have cytochrome p450 2C19 poor metabolizer genes causing certain SSRIs like escitalopram (lexapro) to not work. They may require higher dosing or different meds